Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies
Read MoreNovo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies
Read MoreThe Food and Drug Administration said Novo Nordisk’s TV advertisement for its newly launched Wegovy pill for obesity included “false
Read MoreCheck out the companies making headlines in midday trading. Centene — Shares of the health insurance provider slid 5%. Guidance
Read MoreThese are the stocks posting the largest moves in premarket trading. This article was originally published by a Cnbc.com. Read
Read MoreMethodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new
Read MoreCheck out the companies making the biggest moves midday: Webtoon Entertainment — Shares rallied 31% after the company reached a
Read MoreCheck out the companies making the biggest moves in premarket trading: Palantir Technologies — The defense technology stock jumped 6.8%
Read MoreCheck out the companies making headlines in extended trading: Palantir — The defense technology stock advanced 4% after second-quarter earnings
Read MoreHims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk’s patent on its branded
Read MoreCheck out the companies making headlines before the bell. Target — Target’s shares tumbled more than 7% after first-quarter earnings
Read MoreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.